| FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis JH Paik, R Kollipara, G Chu, H Ji, Y Xiao, Z Ding, L Miao, Z Tothova, ... Cell 128 (2), 309-323, 2007 | 1196 | 2007 |
| International Myeloma Working Group molecular classification of multiple myeloma: spotlight review R Fonseca, PL Bergsagel, J Drach, J Shaughnessy, N Gutierrez, ... Leukemia 23 (12), 2210-2221, 2009 | 1188 | 2009 |
| Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis NE Sharpless, N Bardeesy, KH Lee, D Carrasco, DH Castrillon, ... Nature 413 (6851), 86-91, 2001 | 998 | 2001 |
| Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family F Weih, D Carrasco, SK Durham, DS Barton, CA Rizzo, RP Ryseck, ... Cell 80 (2), 331-340, 1995 | 993 | 1995 |
| Pretreatment mitochondrial priming correlates with clinical response to cytotoxic chemotherapy TN Chonghaile, KA Sarosiek, TT Vo, JA Ryan, A Tammareddi, ... Science 334 (6059), 1129-1133, 2011 | 638 | 2011 |
| A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistance D Chauhan, Z Tian, B Nicholson, KGS Kumar, B Zhou, R Carrasco, ... Cancer cell 22 (3), 345-358, 2012 | 572 | 2012 |
| High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients DR Carrasco, G Tonon, Y Huang, Y Zhang, R Sinha, B Feng, JP Stewart, ... Cancer cell 9 (4), 313-325, 2006 | 524 | 2006 |
| Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages JL Guerriero, A Sotayo, HE Ponichtera, JA Castrillon, AL Pourzia, ... Nature 543 (7645), 428-432, 2017 | 491 | 2017 |
| The differentiation and stress response factor XBP-1 drives multiple myeloma pathogenesis DR Carrasco, K Sukhdeo, M Protopopova, R Sinha, M Enos, DE Carrasco, ... Cancer cell 11 (4), 349-360, 2007 | 491 | 2007 |
| Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation N Bardeesy, M Sinha, AF Hezel, S Signoretti, NA Hathaway, ... Nature 419 (6903), 162-167, 2002 | 481 | 2002 |
| Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing KK Wong, RS Maser, RM Bachoo, J Menon, DR Carrasco, Y Gu, FW Alt, ... Nature 421 (6923), 643-648, 2003 | 458 | 2003 |
| Bortezomib induces canonical nuclear factor-κB activation in multiple myeloma cells T Hideshima, H Ikeda, D Chauhan, Y Okawa, N Raje, K Podar, ... Blood, The Journal of the American Society of Hematology 114 (5), 1046-1052, 2009 | 446 | 2009 |
| Constitutive telomerase expression promotes mammary carcinomas in aging mice SE Artandi, S Alson, MK Tietze, NE Sharpless, S Ye, RA Greenberg, ... Proceedings of the National Academy of Sciences 99 (12), 8191-8196, 2002 | 395 | 2002 |
| Pathogenesis of myeloma KC Anderson, RD Carrasco Annual Review of Pathology: Mechanisms of Disease 6, 249-274, 2011 | 374 | 2011 |
| Relative mitochondrial priming of myeloblasts and normal HSCs determines chemotherapeutic success in AML TT Vo, J Ryan, R Carrasco, D Neuberg, DJ Rossi, RM Stone, ... Cell 151 (2), 344-355, 2012 | 372 | 2012 |
| Hypoxia promotes dissemination of multiple myeloma through acquisition of epithelial to mesenchymal transition-like features AK Azab, J Hu, P Quang, F Azab, C Pitsillides, R Awwad, B Thompson, ... Blood, The Journal of the American Society of Hematology 119 (24), 5782-5794, 2012 | 354 | 2012 |
| A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance Z Tian, P D’Arcy, X Wang, A Ray, YT Tai, Y Hu, RD Carrasco, ... Blood, The Journal of the American Society of Hematology 123 (5), 706-716, 2014 | 338 | 2014 |
| MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myeloma M Jinushi, M Vanneman, NC Munshi, YT Tai, RH Prabhala, J Ritz, ... Proceedings of the National Academy of Sciences 105 (4), 1285-1290, 2008 | 324 | 2008 |
| Rescue of Hippo coactivator YAP1 triggers DNA damage–induced apoptosis in hematological cancers F Cottini, T Hideshima, C Xu, M Sattler, M Dori, L Agnelli, E Ten Hacken, ... Nature medicine 20 (6), 599-606, 2014 | 318 | 2014 |
| A novel Aurora-A kinase inhibitor MLN8237 induces cytotoxicity and cell-cycle arrest in multiple myeloma G Görgün, E Calabrese, T Hideshima, J Ecsedy, G Perrone, M Mani, ... Blood, The Journal of the American Society of Hematology 115 (25), 5202-5213, 2010 | 315 | 2010 |
